New York City, NY, United States of America

Andrew Jacob Nelson

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Mako Surgical Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Jacob Nelson. Retrieved from https://idiyas.com/inventor/andrew-jacob-nelson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Andrew Jacob Nelson and His Surgical Tool Guard Patent.

Introduction

Andrew Jacob Nelson is an inventor associated with New York City, New York. His patent work includes a surgical tool guard designed for use with a surgical device.

Latest Patents

Nelson is credited with 1 patent, titled “Surgical Tool Guard.” The invention describes a guard for an elongated surgical tool with an energy applicator at its distal end. Its body connects to the surgical device and includes a bore through which the tool’s elongated member passes. A thermal mitigation channel between the body’s interior and exterior surfaces opens through at least one exterior port.

Career Highlights

Nelson is associated with Mako Surgical Corporation. His patent focuses on a guard structure that incorporates thermal mitigation features for a surgical tool.

Collaborations

Jeremiah Beers is identified as Nelson’s coworker. The available information does not specify whether they collaborated on the patent.

Conclusion

Andrew Jacob Nelson’s “Surgical Tool Guard” patent describes a surgical-device accessory with a channel intended to mitigate heat, reflecting his contribution to surgical tool design.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…